U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H24N2OS.ClH
Molecular Weight 364.933
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVOMEPROMAZINE HYDROCHLORIDE

SMILES

Cl.COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1

InChI

InChIKey=ODLGFPIWRAEFAN-PFEQFJNWSA-N
InChI=1S/C19H24N2OS.ClH/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21;/h5-11,14H,12-13H2,1-4H3;1H/t14-;/m1./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
LEVOMEPROMAZINE HYDROCHLORIDE
EP   JAN   MART.   MI   USAN   WHO-DD  
USAN  
Official Name English
LEVOMEPROMAZINE HYDROCHLORIDE [MI]
Common Name English
LEVOMEPROMAZINE HYDROCHLORIDE [MART.]
Common Name English
LEVOMEPROMAZINE HYDROCHLORIDE [USAN]
Common Name English
(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine hydrochloride
Systematic Name English
METHOTRIMEPRAZINE HYDROCHLORIDE
Common Name English
LEVOMEPROMAZINE HYDROCHLORIDE [JAN]
Common Name English
LEVOMEPROMAZINE HYDROCHLORIDE [EP MONOGRAPH]
Common Name English
Levomepromazine hydrochloride [WHO-DD]
Common Name English
10H-PHENOTHIAZINE-10-PROPANAMINE, 2-METHOXY-N,N,.BETA.-TRIMETHYL, MONOHYDROCHLORIDE, (.BETA.R)
Common Name English
LEVOMEPROMAZINE HCL
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C740
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID20924552
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
ChEMBL
CHEMBL1764
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
SMS_ID
100000090562
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
FDA UNII
42BB1Y2586
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
CAS
4185-80-2
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
ALTERNATIVE
RXCUI
91124
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY RxNorm
CAS
1236-99-3
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
MERCK INDEX
m6788
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY Merck Index
NCI_THESAURUS
C78109
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
USAN
PP-31
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
ECHA (EC/EINECS)
214-978-3
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
EVMPD
SUB02908MIG
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
PUBCHEM
11954230
Created by admin on Fri Dec 15 15:53:30 UTC 2023 , Edited by admin on Fri Dec 15 15:53:30 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of LEVOMEPROMAZINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966